Lilly expands R&D footprint in Singapore with SGD$42 million investment in new Digital Health Innovation Hub
Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lilly and Company (Lilly), today announced the establishment of a SGD$42 million Digital…